Ad
related to: clinical picture of meningitis vaccine- 114 W 3rd Ave, Columbus, OH · Directions · (614) 456-1108
- Stay Well This Season
Walgreens Has What You Need
To Feel Your Best.
- One Trip. All done.
Schedule The Vaccines You Need
In One Visit To Stay Protected
- Find a Location
Find Your Nearest Walgreens
Today For All Your Vaccines
- Vaccines At Walgreens
Learn What Vaccines Are Recommended
To Help Protect You
- Stay Well This Season
Search results
Results from the WOW.Com Content Network
Meningococcal_meningitis_A,C,Y,W-135_Vaccine.png (226 × 536 pixels, file size: 191 KB, MIME type: image/png) This is a file from the Wikimedia Commons . Information from its description page there is shown below.
NmVac4-A/C/Y/W-135 is the commercial name for a polysaccharide vaccine that protects against meningococcal meningitis caused by Neisseria meningitidis, specifically the serotypes A, C, Y, and W-135. This vaccine is part of a broader group of meningococcal vaccines .
Due to a similarly high prevalence of B-serotype meningitis in Norway between 1974 and 1988, Norwegian health authorities developed a vaccine specifically designed for Norwegian children and adolescents. Clinical trials were discontinued after the vaccine was shown to cover only slightly more than 50% of all cases. [52]
Penbraya is a pentavalent conjugate vaccine developed by Pfizer for the prevention of invasive meningococcal disease in people 10 through 25 years of age. [4] Invasive meningococcal disease, caused by the bacterium Neisseria meningitidis, can lead to serious conditions such as meningitis (inflammation of the brain and spinal cord lining) and sepsis. [5]
Glaxo (GSK) starts dosing with a phase III study on it 5-in-1 meningitis vaccine candidate.
Meningococcal meningitis is a form of bacterial meningitis. Meningitis is a disease caused by inflammation and irritation of the meninges, the membranes surrounding the brain and spinal cord. In meningococcal meningitis this is caused by the bacteria invading the cerebrospinal fluid and circulating through the central nervous system. Sub ...
The FDA accepts for review Sanofi's (SNY) BLA for MenQuadfi, a meningococcal vaccine candidate, presently under development to prevent meningococcal meningitis.
A meningococcal polysaccharide vaccine (MPSV4) has been available since the 1970s and is the only meningococcal vaccine licensed for people older than 55. MPSV4 may be used in people 2–55 years old if the MCV4 vaccines are not available or contraindicated. Two meningococcal conjugate vaccines (MCV4) are licensed for use in the U.S. The first ...
Ad
related to: clinical picture of meningitis vaccine- 114 W 3rd Ave, Columbus, OH · Directions · (614) 456-1108
